We are studying whether spironolactone can help reduce heart deterioration and arrhythmias in patients with ARVD. This trial compares its effects to a placebo over one and three years.
Health conditions and diseases that the clinical trial is designed to study and treat.
Arrhythmogenic Right Ventricular Dysplasia (ARVD) is a rare heart condition where the heart muscle is replaced by fatty or fibrous tissue, leading to arrhythmias and potential heart failure. It primarily affects the right ventricle and can cause irregular heartbeats.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.